Acesso a medicamentos

Receba RSS dos resultados

Histórias e componentes nesta categoria

Resposta
16 April 2018
+ English - Ocultar

Autor: Novartis

At Novartis, corporate responsibility (CR) is central to how we run our business. Our CR strategy supports our company mission to discover new ways to improve and extend people’s lives and our vision to be a trusted leader in changing the practice of...

Veja a resposta completa

Artigo
15 April 2018
+ English - Ocultar

Autor: Louise Moon, South China Morning Post

A Chinese doctor [Tan Qindong] is under investigation for describing as “poison” a “medicinal liquor” that has repeatedly been banned over false claims about its health benefits…after receiving a complaint from the Hongmao Wine company, Beijing Youth...

Leia mais

Artigo
19 March 2018
+ Español - Ocultar

Autor: Prensa Libre (Guatemala)

“Heridas de pacientes se abren por hilos para sutura defectuosos; Salud retira medicamento”, 16 de marzo de 2018...

Leia mais

Artigo
14 November 2017
+ English - Ocultar

Autor: European Commission

In its interim report, published in July 2017, the High Level Expert Group on sustainable finance recommended the Commission to clarify that the fiduciary duties (duties of loyalty and prudence) of institutional investors and asset managers explicit...

Leia mais

Artigo
28 September 2017
+ Español - Ocultar

Autor: El Espectador

“Se buscan médicos sin conflictos de interés” - 21 de septiembre de 2017...

Leia mais

Artigo
17 August 2017
+ English - Ocultar

Autor: David Gelles, Landon Thomas Jr., Andrew Ross Sorkin & Kate Kellyaug, NY Times (USA)

On Tuesday, Indra Nooyi, the chief executive of PepsiCo, joined a call with other prominent corporate chieftains who...had agreed to advise...Trump. A rebellion was brewing. Along with other business leaders, [she]...watched with bafflement over the...

Leia mais

Artigo
9 July 2017
+ English - Ocultar

Autor: Sarah Neville, Financial Times (UK)

The UK drugs industry is going to court in an attempt to stop the country’s taxpayer-funded National Health Service from imposing new limits on the price it will pay for medicines. The action follows a government crackdown in April that limits funding...

Leia mais

Artigo
26 May 2017
+ Français - Ocultar

Autor: Ram Etwareea, Le Temps (Suisse)

« Novartis attaque la Colombie en justice », 23 mai 2017...

Leia mais

Artigo
19 April 2017
+ Français - Ocultar

Autor: Bilan (Suisse)

« Novartis accusé de pression sur la Colombie », 12 avril 2017...

Leia mais

Artigo
12 April 2017
+ English - Ocultar

Autor: Public Eye

"Compulsory licensing in Colombia: Leaked documents show aggressive lobbying by Novartis", 11 Apr 2017...

Leia mais